| NCT Number | NCT07546214 |
| Lead Sponsor | Sun Pharmaceutical Industries, Inc. |
| Conditions | Plaque Psoriasis |
| Enrollment | 575 participants |
| Start Date | 2025-10-13 |
| Primary Completion | 2026-03-18 (estimated) |
| Study Completion | 2026-03-18 (estimated) |
| Updated on ClinicalTrials.gov | 2026-04-22 |